| Vichit Vanadurongvan, MD | |
|
803 E Milbank Ave, Milbank, SD 57252-1413 | |
| (605) 432-4587 | |
| (605) 432-4580 |
| Full Name | Vichit Vanadurongvan |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 803 E Milbank Ave, Milbank, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649234428 | NPI | - | NPPES |
| 7300224 | Medicaid | SD | |
| 629363800 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 2310 (South Dakota) | Primary |
| Entity Name | Avera Mckennan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003389206 PECOS PAC ID: 0345157103 Enrollment ID: O20031110000117 |
News Archive
Celsion Corporation, an oncology drug development company, today announced updated results from its retrospective analysis of the Company's 701-patient HEAT Study of ThermoDox, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin in combination with radiofrequency ablation (RFA) in primary liver cancer, also known as hepatocellular carcinoma (HCC).
Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today announced financial results and achievements for the quarter ended March 31, 2011.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Response Biomedical Corporation reported financial results for the first quarter ended March 31, 2011. Total revenues for the three-month period ended March 31, 2011 increased 59% to $2,470,560 compared to $1,549,479 for the same period last year.
Researchers at Brigham and Women's Hospital (BWH) have demonstrated that the circadian system, the body's internal clock, regulates human platelet function and causes a peak in platelet activation corresponding to the known morning peak in adverse cardiovascular events. These findings are published in PLoS ONE on September 8, 2011.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vichit Vanadurongvan, MD 13516 Sodak Rd, Wilmot, SD 57279-8211 Ph: (605) 938-4574 | Vichit Vanadurongvan, MD 803 E Milbank Ave, Milbank, SD 57252-1413 Ph: (605) 432-4587 |
News Archive
Celsion Corporation, an oncology drug development company, today announced updated results from its retrospective analysis of the Company's 701-patient HEAT Study of ThermoDox, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin in combination with radiofrequency ablation (RFA) in primary liver cancer, also known as hepatocellular carcinoma (HCC).
Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today announced financial results and achievements for the quarter ended March 31, 2011.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Response Biomedical Corporation reported financial results for the first quarter ended March 31, 2011. Total revenues for the three-month period ended March 31, 2011 increased 59% to $2,470,560 compared to $1,549,479 for the same period last year.
Researchers at Brigham and Women's Hospital (BWH) have demonstrated that the circadian system, the body's internal clock, regulates human platelet function and causes a peak in platelet activation corresponding to the known morning peak in adverse cardiovascular events. These findings are published in PLoS ONE on September 8, 2011.
› Verified 7 days ago
Kanya Vanadurongvan, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 803 E Milbank Ave, Milbank, SD 57252 Phone: 605-432-4587 Fax: 605-432-4580 |